Biologics

For its groundbreaking work in sustaining global health systems in a year of geopolitical turbulence, Xenco Medical has been awarded the prestigious Excellence in Governance and Leadership for Global Challenges Award by the World Economic Forum for its role in…

Spine biologics companies are navigating unprecedented commercial pressure and accelerating technological change.  As demand for regenerative solutions grows and competition intensifies, leaders are forming strategic partnerships to strengthen distribution channels, advance product pipelines and meet surgeon expectations. The pace of…

Melville, N.Y.-based BioRestorative Therapies has secured a Type B meeting with the FDA to discuss an accelerated approval path for its fast-track-designated BRTX-100 program for chronic lumbar disc disease. The meeting is scheduled for mid-December. In a Nov. 17 news…

Here are spine spine and orthobiologics technologies that have received FDA approval so far this year, as reported by Becker’s.  Note: This list is not exhaustive. 

Regenerative medicine in spine and orthopedics is a promising area of care with medtech companies pushing into the space and physicians exploring their options. Here’s what spine and orthopedic experts predict for the short- and long-term. In 12 months Brian…

Vivek Babaria, DO, FAAPMR, is cautiously optimistic about what’s next for regenerative medicine, and as an interventional spine and sports medicine physician, he’s focused on the data that will drive it forward. Dr. Babaria of DISC Sports & Spine Center,…

Exploring regenerative medicine and orthobiologics has been a top priority at Chicago-based Midwest Orthopaedics at Rush, and it’s just the beginning for innovation, Brian Cole, MD, said. Dr. Cole, managing partner, spoke with Becker’s about what he anticipates for orthobiologics…

Xtant Medical’s CollagenX wound healing product is out in a full commercial launch, according to a Nov. 6 news release. CollagenX is a bovine collagen particulate for surgical wound closure designed to promote healing, prevent dehiscence and reduce surgical site…

James Petros, MD, has launched OrthoGen Health, a regenerative medicine practice in San Jose, Calif. The practice provides orthobiologic treatments and non-surgical care for patients with joint pain, arthritis, sports injuries and chronic musculoskeletal conditions, according to an Oct. 14…

Here are five developments in orthobiologics since Sept. 5. 1. Lenoss Medical’s OsteoPearl biologic allograft for spine earned two new U.S. patents and one European patent. 2. Keensight Capital, a private equity manager, has acquired a majority stake in regenerative…